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Nucleic acid aptamers possess attractive features such as specific molecular recognition, high-
affinity binding, and rapid acquisition and replication, which could be feasible components for 
separating specific cells from other cell types. This study demonstrates that aptamers conjugated 
to an oligopeptide self-assembled monolayer (SAM) can be used to selectively trap human hepatic 
cancer cells from cell mixtures containing normal human hepatocytes or human fibroblasts. Molecular 
dynamics calculations have been performed to understand how the configurations of the aptamers 
are related to the experimental results of selective cell capture. We further demonstrate that the 
captured hepatic cancer cells can be detached and collected along with electrochemical desorption 
of the oligopeptide SAM, and by repeating these catch-and-release processes, target cells can be 
enriched. This combination of capture with aptamers and detachment with electrochemical reactions 
is a promising tool in various research fields ranging from basic cancer research to tissue engineering 
applications.
Isolation of target cells from a mixture is fundamental in various research fields associated with cell culture including 
molecular cell biology, cancer research, and regenerative medicine. Several approaches have been employed to 
harvest target cells such as cancer cells, parenchymal cells, and stem or differentiated cells for subsequent culture 
and analysis1–3. Conventional approaches include density-gradient centrifugation and size-dependent microflu-
idic filtration4. However, a major limitation of these approaches is the lack of specificity to target cells because of 
overlaps of cell densities and sizes between the targets and other cells. Fluorescent- and magnetic-activated cell 
sorting methods have therefore emerged in the past decades and are now commercially available. Antibodies 
against cell surface molecules are responsible for the specificity to target cells in these approaches. A potential 
drawback of the use of antibodies is that specific membrane proteins and their arrangement need to be previously 
elucidated to acquire antibodies against target cells.
Nucleic acid aptamers provide an attractive and practical alternative5,6. Without prior knowledge of distinct 
marker proteins, aptamers against specific cells can be selected from pools of random-sequence oligonucleotides 
by means of so-called cell-SELEX (cell-systematic evolution of ligands by exponential enrichment)7,8. Aptamers 
bind to marker molecules with high specificity and affinity comparable to those of antibodies. In addition, aptam-
ers possess several advantages over typical antibodies including rapid (< 1 week) in vitro acquisition and repli-
cation9,10, stable long-term storage as a powder or solution, and easy and controllable modification11,12. Several 
reports have already shown that aptamers can be used for capturing target cells and subsequently releasing them 
for following analysis13. For example, lymphoblasts were captured on an aptamer-displayed substrate and then 
released by dissociating aptamer-cell binding with complementary nucleic acids14. Although the feasibility of 
the aptamer-based approach has been primarily examined for non-adherent cell populations such as blood cells, 
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its adaptation to adherent cell populations still lags behind. This is probably because surfaces need to be more 
precisely designed to prevent random cell adhesion. To the best of our knowledge, there is no report showing the 
isolation and collection of adherent cells from other adherent cells using an aptamer-modified substrate.
The present study describes a design of culture substrates covered with an aptamer-conjugated oligopep-
tide layer for the isolation of adherent cells, using molecular dynamics (MD) calculations and experiments. 
In the cell isolation, a cell-repulsive background is responsible for preventing non-specific protein adsorption 
and thus non-specific cell adhesion. To this end, we employed zwitterionic oligopeptides that formed a dense 
self-assembled monolayer (SAM) on a gold substrate and served as a cell-repulsive background15. Another critical 
factor for the specific cell capture is the difference in binding affinity to an aptamer between target and non-target 
cells. We investigated the configurations of an aptamer in bulk and after conjugation to the oligopeptide SAM 
using MD calculations, because these could be responsible for the affinity. Electrochemical reactions have been 
used to desorb the SAM by cleaving the bond between the SAM and gold16,17. We hypothesized that target cells 
captured on the aptamer-conjugated SAM can be collected by applying an electrochemical potential (Fig. 1). 
Using human hepatic cancer cells as a target and normal human hepatocyte or human fibroblasts as non-targets, 
we examined whether the aptamer-conjugated surface can be used to selectively capture and then release the 
target cells without sever cytotoxicity.
Results and Discussion
Conformation of aptamer in bulk. A single-stranded DNA aptamer that specifically rec-
ognizes hepatic cancer cells was selected for the present study. The sequence of the aptamer is 
5′ - TAACTCAATAAGCTAGGTGGGTGGGGGACACTACTCGGGGGTGGTTGGGT-3′ , which was previously 
obtained by means of cell-SELEX using human hepatoma Hep G2 cells as targets and human normal hepatocytes 
as counterparts18. Here we calculated the conformations of the single aptamer in explicit water, showing that a 
part of the aptamer (nucleotides GUA27 to THY18) forms a handle structure that is maintained until the end 
of the simulation (Fig. 2A). This region is similar to that predicted previously using the mfold web server18. We 
further tested the approximation of the implicit solvent, showing that it leads to similar results comparable to 
that in an explicit solvent. In particular, the end-to-end distance (139.47 ± 9.50 Å in explicit, 111.05 ± 19.27 Å in 
implicit), the radius of gyration (44.30 ± 0.82 Å in explicit, 38.81 ± 3.37 Å in implicit), and the persistence length 
(42.35 ± 1.88 Å in explicit, 43.54 ± 5.50 Å in implicit) showed no statistically significant difference. Subsequent 
simulations were therefore conducted in an implicit solvent.
Behavior of aptamer on oligopeptide SAM. A hydrated and electrically neutral surface is low-fouling 
to the non-specific adsorption of proteins, and thus, cells. Zwitterionic polymers, such as poly(carboxybetaine) 
and poly(sulfobetaine), have been used to prepare anti-fouling surfaces19. Surfaces modified with zwitteri-
onic oligopeptides, such as repeated lysine-glutamic acid (KE) or lysine-aspartic acid (KD) (i.e. EKEKEKE or 
DKDKDKD), also exhibit strong resistance to protein adsorption and cell adhesion15,17. In the present study, the 
oligopeptide, CGGGKEKEKEK, was designed to form a cell-repulsive SAM on a gold surface due to electrostatic 
Figure 1. Concept of catch-and-release of target cells. (A) Procedures for selective capture and subsequent 
detachment of target cells using a surface modified with the zwitterionic oligopeptide SAM and the aptamer. 
(B) Setup of the two-electrode system consisting of a gold working electrode (W.E.) and a Ag/AgCl reference 
electrode (R.E.). The gold substrate was connected to four clips to alleviate a voltage drop.
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forces generated by the alternating positive (K) and negative (E) amino acids between neighboring oligopeptides 
(Figure S1, Supporting Information)17. The aptamer was conjugated to the oligopeptide SAM with azide-alkyne 
cycloaddition through copper-catalyzed click chemistry (Fig. 1). The dependence of aptamer configurations 
on its density (1%, 2%, and 3% aptamer density with respect to the number of oligopeptides) was examined 
using MD calculations in implicit solvents. The aptamer shows striking differences in behavior in the three dif-
ferent conditions (Fig. 2B). At the lowest density (1%), the aptamer flattens on the oligopeptide SAM surface. 
Conversely, at the higher aptamer densities (2% and 3%), the aptamer is extended towards the solvent for 14.7 nm 
and 18.9 nm, respectively. These different tendencies can be explained by the fact that the increase in the density 
lowers the relative distance between negatively charged aptamers (~100 nm, 1%; ~33 nm, 3%), which repulse each 
Figure 2. MD simulations of aptamer in bulk and on oligopeptide SAM. (A) Changes in aptamer 
configuration in explicit solvent in bulk. The values indicate periods of MD calculation. (B) Aptamer 
configuration on the oligopeptide SAM in implicit solvent. The values indicate the aptamer density (aptamer/
oligopeptide). Gold layers (pink), oligopeptide SAMs (cyan), and aptamers (red) were visualized by VMD 
software.
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other, preventing the aptamer from flattening on the peptide surface. The configurations of the aptamer may be 
responsible for its affinity to specific cells and such correlations were observed in experiments as discussed below 
(Fig. 3D).
Experimental characterizations of aptamer-conjugated oligopeptide SAM. To conjugate the 
aptamer to the oligopeptide SAM using the azide-alkyne click chemistry reaction20,21, the alkyne was coupled 
to the hydroxyl group of 5′ thymine of the aptamer, using the alkyne-modifier serinol phosphoramidite (Glen 
Research, USA), and the NH2 of the K (Lys) at the C-terminus was replaced with an azide (-N3). The oligopep-
tides with and without azide groups (peptide-N3 and peptide-COOH) were mixed in an aqueous solution at a 
ratio of 1:9, of which drops were then placed on a gold-coated glass substrate. Because a thiol group containing 
cysteine spontaneously binds to gold through gold-thiolate bonding, the oligopeptides chemically adsorb and 
form a SAM on the gold substrate. We quantified the adsorption of the oligopeptides and subsequent conjuga-
tion of the aptamer with click chemistry using a quartz crystal microbalance (QCM). The adsorbed amounts 
of oligopeptides and aptamer were ~0.16 nmol/cm2 and ~4.7 pmol/cm2, respectively. These values indicate that 
the oligopeptides formed a dense molecular layer, which was sufficient to block non-specific adsorption of pro-
teins (see below), and that the number of aptamers against oligopeptides was approximately 3:100 based on their 
molecular weights. QCM was further employed to examine the non-fouling properties of the oligopeptide SAM 
and the aptamer-conjugated SAM. In the measurements, the surfaces were exposed to culture media containing 
fibronectin (a cell-adhesive protein) and 10% fetal bovine serum (FBS, a mixture of various proteins). As shown 
in Fig. 3A, the adsorptions of both fibronectin and FBS proteins were significantly reduced on the oligopeptide 
SAM compared to those on a bare gold surface. However, the adsorption of fibronectin (75.3 ng/cm2) was much 
higher than that on a SAM composed of only peptide-COOH in our previous study (44.2 ng/cm2)17. This is likely 
because the addition of 10% peptide-N3 altered the balances of electrostatic and/or hydrophilic/hydrophobic 
Figure 3. Non-specific protein adsorption and selective cell capture. (A) Protein-repulsive characteristics 
on oligopeptide SAMs. Bare gold surface (open column), the SAM surface (striped column), and the aptamer-
conjugated SAM surface (solid column) were exposed to fibronectin and proteins in 10% FBS. The error bars 
indicate the standard deviations calculated from four independent experiments with QCM. (B,C) Hep G2 cells 
and RFP-HNDFCs captured on an aptamer-modified surface. Phase-contrast and fluorescent images were 
merged. Red fluorescence signal indicates RFP-HNDFCs. The two cell types were seeded at a ratio of 1:1 on 
the gold surfaces modified with (a) 3% aptamer/oligopeptide, or (b) without any modification. (D) Selective 
cell capture on SAMs modified with aptamer. A mixed suspension of Hep G2 cells (target, solid column) and 
HNDFCs (non-target, open column) was seeded on the aptamer-SAM surfaces of different aptamer densities. 
The relative density of aptamer represents the molar ratio of the aptamer to the oligopeptide calculated from 
QCM data. The error bars indicate the standard deviations calculated from nine independent experiments. 
*p < 0.05.
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conditions while the oligopeptide without azide groups was originally designed to form a SAM with electrically 
neutral and highly hydrophilic characteristics. The conjugation of the aptamer on the SAM further increased the 
adsorption of fibronectin and proteins in FBS probably because of its negative charge and hydrophobicity.
Dependence of cell capture efficiency on mixing ratio of peptide-N3. The results from the MD 
simulations and QCM measurements indicate that the density of aptamers is closely involved in both the config-
uration of the aptamer (thus cell binding affinity) and non-specific protein adsorption. Since the aptamer density 
could be readily modulated by changing the mixing ratio of peptide-N3 to peptide-COOH, we examined the 
number of target cells captured and the target/non-target ratio on different aptamer-conjugated SAM surfaces 
when prepared with 0.1%, 1%, 10%, and 100% peptide-N3. Note that the aptamer density (aptamer/oligopep-
tide) was defined in this study based on the QCM results as 0.03%, 0.3%, 3%, and 30% when the mixing ratio 
of peptide-N3 were 0.1%, 1%, 10%, and 100%, respectively. As controls, a bare gold surface (bare gold) and a 
surface without oligopeptide layer (aptamer only) was examined. A cell suspension mixture containing Hep G2 
cells (targets, 1 × 105 cells/2 mL) and red fluorescent protein expressing human neonatal dermal fibroblast cells 
(RFP-HNDFCs, non-targets, 1 × 105 cells/2 mL) were seeded on the aptamer-conjugated SAM surfaces in a typ-
ical 6-well culture plate. After 3 h of culture, phase-contrast and fluorescent microscopic images were taken and 
the number of each cell type was counted (Fig. 3B and C). The resultant target/non-target ratios were improved 
on the surfaces of 0.03%, 0.3%, and 3% aptamer/oligopeptide and no significant difference was observed between 
them (Fig. 3D). However, the total number of captured Hep G2 cells in 3% aptamer/oligopeptide was three to four 
times greater than those on 0.03% and 0.3% aptamer/oligopeptide and reached ~70% of that on bare gold. These 
are possibly consistent with the results obtained with MD simulations, where the aptamer flattens on the SAM in 
< 1% aptamer/oligopeptide but is exposed toward bulk at > 2% aptamer/oligopeptide. On 30% aptamer/oligopep-
tide, the number of attached Hep G2 cells increased and the capture efficiency reached 35%, which was greater 
than that on the 3% aptamer/oligopeptide surface (~20%). However, adhesion of HNDFCs also significantly 
increased and the purity dropped from 85% on the 3% aptamer/oligopeptide surface to 61% on the 30% aptamer/
oligopeptide surface. This was probably because the net surface charge became negative due to the increased 
number of aptamers. Based on these results, we used 3% aptamer/oligopeptide in the following experiments.
Harvesting captured cells using electrochemistry. The gold-thiolate bond can be reductively cleaved 
by applying a negative electrochemical potential. With this reaction, we previously demonstrated that cells 
attached on alkanethiol or oligopeptide SAMs were detached along with the desorption of SAMs17,22–25. Here 
we examined whether using the same electrochemical reaction, the aptamer-conjugated oligopeptide SAM is 
cleavable and whether captured cells can be collected. Cyclic voltammetry was employed to determine the poten-
tial required for the reductive desorption. The results showed that the peak potential appeared at − 0.87 V with 
respect to Ag/AgCl in the first scan, which decayed in the second and third scans, showing that the gold-thiolate 
bond of the aptamer-conjugated SAM was cleaved at this potential (Fig. 4A). It was reported with alkanethiol 
SAMs that the peak potential was associated with the stability of SAMs and became more negative in SAMs with 
longer alkyl chains26,27. Because the peak potential of the aptamer-conjugated SAM was almost the same as that 
of the oligopeptide SAM, the mixing of the azide-modified oligopeptide and conjugation with the aptamer may 
not be involved in the stability. We decided to use − 1.0 V with respect to Ag/AgCl, a negative potential that is 
sufficiently greater than the peak, to harvest cells in the subsequent experiments because the cell membrane could 
be electrically resistant and cause a potential drop. As expected, Hep G2 cells captured on the aptamer-conjugated 
SAM were detached from the surface by applying − 1.0 V with respect to Ag/AgCl for 5 min (Fig. 4B and C). 
Quantitative analysis of the detachment was carried out by counting the number of Hep G2 cells on the substrate 
before and after the potential application (Fig. 4D). More than 97% of the cells were detached with 5 min of poten-
tial application. Moreover, it is noteworthy that ~20% of captured cells were detached without potential appli-
cation. This is probably because the control samples experienced the same procedures as did the samples with 
potential application, including removal of culture medium, washing with PBS, and placement onto the electrode 
system (see the image in Fig. 1). To check the viable conditions of the cells collected with the electrochemical 
reaction, live/dead fluorescent staining (Fig. 4E) and proliferation assay (Fig. 4F) were conducted. There was no 
significant difference in the viability and proliferation rate between the cells collected with the electrochemical 
reaction and with a typical trypsin treatment, showing that electrochemical detachment is a non-cytotoxic and 
cell-friendly approach on at least the same level as the optimized trypsin treatment. This rapid and non-cytotoxic 
cell detachment approach could be a great advantage compared with other approaches using cDNA or endonu-
clease (10–30 min), particularly when the processes are repeated to obtain a high purity of cell population28–30.
Liver-specific functions of enriched Hep G2 cells. The hepatic functions of Hep G2 cells were evaluated 
after they were enriched from a mixture with HNDFCs on the aptamer-conjugated SAM, collected with the elec-
trochemical reaction, and seeded at 3 × 104 cells/well on a conventional 24-well plate. For comparison, cells that 
had not been captured on the SAM in the 3-h incubation were collected and seeded at the same cell density on 
a 24-well plate. Further, the original cell suspension before the enrichment containing an equal number of Hep 
G2 cells and HNDFCs was seeded on a 24-well plate at the same cell density. Culture media in all three cultures 
were sampled every 24 h over 4 days and the concentrations of albumin and fibrinogen were determined. At days 
1 and 2, there was no significant difference in the secretion of both proteins between the cultures with or without 
cell enrichment, while thereafter the effects of the enrichment became apparent (Fig. 5). Although co-culture of 
hepatocytes with fibroblasts typically upregulates hepatic functions including albumin secretion31, Hep G2 cells is 
derived from hepatoblastoma and could be less sensitive to surrounding cells and microenvironments. The results 
are more likely attributed to the proliferation of Hep G2 cells.
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Figure 4. Characterizations of electrochemical cell detachment. (A) Cyclic voltammograms during reductive 
desorption of the peptide-aptamer layer. The digits 1, 2, and 3 indicate the scan numbers. The scanning rate 
was 20 mV/s. (B,C) Phase-contrast images of Hep G2 cells on a gold surface before and after the application 
of − 1.0 V with respect to Ag/AgCl. (D) Quantitative analysis of the electrochemical cell detachment. The 
number of cells was counted after conducting entire procedures for the detachment with (w, striped column) 
and without (w/o, solid column) the potential application. (E) Viability of cells detached by electrochemical 
potential application (EC, striped column) or by treatment using trypsin (solid column). (F) Proliferation of 
electrochemically detached cells. Cells were detached by electrochemical potential application (EC, closed 
circle) or by treatment using trypsin (closed triangle) and re-seeded in a conventional culture dish. Changes in 
the number of cells were counted. (D–F) The values and error bars represent means and standard deviations 
calculated from three independent experiments.
Figure 5. Liver-specific functions of electrochemically detached cells. The secretions of albumin (A) and 
fibrinogen (B) were compared in cell populations in three cultures: cells enriched on the aptamer-SAM and 
collected by electrochemical detachment, cells that did not attach on the aptamer-SAM surface, and cells before 
separation (Hep G2 and HNDFCs were equally mixed). The values and error bars represent mean and standard 
deviations calculated from three independent experiments. *p < 0.05.
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Multiple enrichment of target cells. The aptamer-conjugated SAM surface was useful in improving the 
purity of Hep G2 cells out of HNDFCs from 50% to 85%. However, this value can be insufficient depending on the 
intended uses or applications. Microfluidics could be a promising solution for this because cell isolation under 
flow shear stress potentially provides an optimum threshold condition for selective cell capture32, facilitating 
cell separation on a denser aptamer, and thus, higher cell affinity surfaces. However, a drawback of microfluidic 
approaches is the limitation on the number of cells that can be processed at once, which makes the system more 
complicated and expensive as seen in fluorescent-activated cell sorting. This in turn compromises the benefits 
gained from aptamers such as inexpensive, rapid acquisition and scalability. A more straightforward way may be 
repeating the enrichment processes using a flat plate. To obtain a separation curve for calculating the number of 
theoretical stages, we prepared cell suspensions with the same total cell number (2 × 105 cells /2 mL/well) but dif-
ferent ratios of Hep G2 cells to HNDFCs (Hep G2: 1%, 20%, 40%, 50%, 60%, 80%, and 99%). The cell suspensions 
were exposed to the aptamer-conjugated SAM surface for 3 h and obtained data were plotted in Fig. 6A. Note 
that the x-axis and y-axis in Fig. 6A indicate the purity before and after the enrichment, respectively. An example 
of prospective changes in the purity through multiple enrichments is shown by the broken lines with arrows in 
Fig. 6A, representing that triple repetition of the enrichment increases the purity from 20% to 97%.
Enrichment of specific cancer cells from normal cells may be an interesting and important application of this 
approach. The same enrichment experiments were conducted using normal human primary hepatocytes instead 
of HNDFCs. As shown in Fig. 6B, much more efficient enrichment of Hep G2 cells was observed against normal 
human hepatocytes than in those purified against HNDFCs. Only through two repetitions of the enrichment 
did the purity increase from 1% to > 95%. This is attributed to the fact that the aptamer was originally designed 
by means of cell-SELEX using human normal hepatocytes as counterparts. On the other hand, the results also 
indicate the possible limitation that a small amount of non-target cells was unexclusive and it may be challenging 
to obtain pure cell populations only by repeating the enrichment processes. Furthermore, although a sample 
containing only 1% of the target cells (2000 cells/mL) could be treated and enriched on the modified surface, 
the error bars were relatively large compared to the number of cells obtained. This implies that cell isolation of a 
sample with a cell concentration less than 2000 cells/mL would be challenging. Further optimisation of peptide 
sequences and isolation times will be necessary to improve this cell isolation limitation. In particular, the peptide 
sequence should be adjusted to make the surface electrically neutral when the aptamer is bonded to prevent any 
non-specific cell adhesion, potentially making it possible to expose cells to the aptamer surface for longer periods 
of time.
We previously demonstrated that electrochemical cell detachment could be conducted at single-cell resolution 
in a specially controlled manner33. On an array of microelectrodes, single cells at specific areas under a micro-
scope were selectively detached on demand by applying a potential to specific microelectrodes under the target 
cells. A combination of the aptamer-conjugated SAM and a microelectrode array could be beneficial to select cells 
with interesting features under a microscope and collect or exclude them for following analysis.
Conclusions
This study describes a cell isolation platform developed using the combination of selective cell attachment with 
an aptamer and non-cytotoxic cell detachment with electrochemistry. An aptamer-conjugated surface was 
designed based on molecular dynamics calculations of aptamers on an oligopeptide SAM and experiments 
Figure 6. Separation curve of target cells. (A) Ratio of Hep G2 (targets) to HNDFCs or (B) ratio of Hep G2 
(targets) to normal human hepatocytes before and after separation using the aptamer-SAM. Broken lines with 
arrows indicate a theoretical example of multistep enrichment. The values and error bars indicate mean and 
standard deviations calculated from three independent experiments.
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using QCM. The aptamer-conjugated oligopeptide SAM sufficiently decreased non-specific protein adsorption 
and was beneficial for specifically attracting hepatic cancer cells from other cell types. The cells captured on the 
aptamer-conjugated SAM surface were detached by potential application for 5 min. The collected cells maintained 
high viability, proliferation activity, and liver-specific functions comparable to those of cells treated with trypsin. 
Although further studies on the repetitions of the processes in a precisely controlled manner and the combina-
tions with microelectrode arrays are required, this non-cytotoxic and versatile cell isolation approach could be a 
useful platform in various fields including basic cancer research and regenerative medicine.
Methods
Cell preparation. Human hepatic cancer cells (Hep G2 cells; RCB1642, Riken Cell Bank, Japan), red fluo-
rescent protein-expressing human neonatal dermal fibroblasts (RFP-HNDFCs; cAP-0008RFP, Angio-Proteomie, 
USA), and normal human hepatocytes (SA152, KaLy-Cell, France) were purchased. Hep G2 cells were main-
tained in Dulbecco’s modified Eagle’s medium (DMEM; Sigma-Aldrich, Japan) supplemented with 10% fetal 
bovine serum (FBS; Sigma-Aldrich, Japan) and 1% penicillin/streptomycin (Life Technologies, USA). RFP-
HNDFCs were maintained in minimum essential medium α (Thermo Fisher, Japan) supplemented with 10% FBS 
and 1% penicillin/streptomycin. The culture media were exchanged every two days and the cells were passaged 
with 0.25% trypsin-EDTA (Thermo Fisher, Japan). When Hep G2 cells were mixed with the other types of cells 
(HNDFCs or normal hepatocytes), we used the culture medium for Hep G2 cells.
Modification of oligopeptides and aptamer on a gold substrate. A glass substrate (24 mm × 24 mm, 
No. 4, Matsunami, Japan) was sputter-coated with a few nanometers of chromium and ~40 nm of gold. The oli-
gopeptide, CGGGKEKEKEK (peptide-COOH; Scrum, Japan), was designed to form a cell-repulsive layer 
on the gold substrate15,17. Its azide-modified form CGGGKEKEKEK-azide (peptide-N3; Toray, Japan) was 
also synthesized. A mixed aqueous solution of these two oligopeptides was prepared at different ratios but 
at a fixed total concentration (50 μ M). The gold-coated substrates were immersed into the oligopeptide mix-
ture solutions overnight at 4 °C. Since the oligopeptides contain cysteine at the N-terminal and the alternat-
ing zwitterionic KE sequence at the C-terminal, the oligopeptides chemically adsorb onto the gold substrate 
via gold-thiol bonding and form a dense self-assembled monolayer (SAM) by electrostatic interactions. 
After washing with phosphate-buffered saline (PBS), the layer was further modified with an aptamer, 5′ 
-alkyne-TAACTCAATAAGCTAGGTGGGTGGGGGACACTACTCGGGGGTGGTTGGGT-3′ (BEX, Japan) 
through azide-alkyne click chemistry20,21 by placing a drop of 0.3 μ M aptamer solution (H2O:t-BuOH, 2:1) con-
taining 1.8 mol% CuSO4 and 8 mol% sodium ascorbate on the substrate and incubating for 8 h at room tempera-
ture. Note that the aptamer sequence was previously designed using cell-SELEX for the selection of Hep G2 cells 
from normal human hepatocytes18. The substrate was then rinsed with PBS and sterilized with 70% ethanol. Each 
substrate was then placed in a 6-well plate (BD Falcon, Japan).
Simulation of oligopeptide and aptamer behaviors. MD simulations were carried out using software 
NAMD2.934 with CHARMM2235 and GolP force field36, and CMAP correction37. Golp-FF force field describes 
the interaction between Au(111) and proteins. The pdb files of the aptamer, azide-alkyne linker, and oligopeptide 
SAM were designed with the software Pymol38, while the gold unit slab file was available with GolP force field. All 
analyses were carried out with VMD software39. We model the aptamer in explicit and implicit solvents in order 
to test the impact of the implicit approximation, which is necessary for the reduction of calculation volume of 
the aptamer-conjugated SAM. The implicit solvent is modeled with the Generalized Born Implicit Solvent. For 
the explicit solvent, the aptamer was solvated in a water box (109 Å × 234 Å × 128 Å) and neutralized with the 
addition of Na+- Cl− ions at physiological concentration (0.15 mol/L). A preliminary minimization of 100,000 
steps was carried out. Subsequently, MD simulation was carried out for a simulation time of 8 ns at a temperature 
of 310 K with a time step of 2 fs. The explicit solvent simulation was run under constant pressure and temperature 
(NPT) conditions (pressure 1 atm, temperature 310 K). The SAM was built at the density obtained from exper-
imental data with QCM. We modeled three different aptamer densities: ~1% (1 aptamer every 108 peptides), 
~2% (1 aptamer every 56 peptides) and ~3% (1 aptamer every 36 peptides). Aptamer-conjugated SAM systems 
are simulated in implicit solvent with the Generalized Born Implicit Solvent. All systems were minimized with 
the steepest descent algorithm for at least 15,000 steps. Subsequently, MD simulations were run until structural 
stability (monitored by root mean square deviation) for a total time of 10–15 ns.
QCM. QCM (AFFINIX QN, Initium, Japan) was used to quantify the stepwise loading of molecules on a 
gold substrate: adsorption of the oligopeptides on the gold surface, binding of the aptamer on the SAM, and 
non-specific adsorption of proteins on the aptamer-conjugated SAM. Briefly, a gold QCM electrode was cleaned 
with piranha solution (H2SO4:H2O2, 3:1), rinsed with double-distilled water (ddH2O; Milli-Q Advantage, 
Millipore-Japan, Japan), and dried under nitrogen gas. The electrode was immersed in a peptide mixture solution 
(peptide-COOH:peptide-N3, 9:1; 50 μ M) overnight at 4 °C, and then rinsed with ddH2O and dried under nitro-
gen gas. The change in resonance frequency before and after the modification in air was measured. The electrode 
was then immersed into a 0.3 μ M aptamer solution and incubated for 8 h at room temperature. The electrode was 
then rinsed with ddH2O and dried, and the change in resonance frequency was measured. In the examinations 
of protein adsorption, the electrodes covered with the aptamer-conjugated SAM were exposed to a 1 mg/mL 
fibronectin (Sigma-Aldrich, Japan) solution or culture medium containing 10% FBS for 1 h at room temperature. 
Changes in resonance frequency before and after the exposures were measured in dried condition. The frequency 
differences were translated to adsorbed amounts using the Sauerbrey equation. An unmodified gold electrode was 
used as a reference surface.
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Selective capture of target cells. Hep G2 cells and RFP-HNDFCs were mixed at 1.0 × 105 cells per cell type 
in 2 mL of culture medium. Aptamer-conjugated oligopeptide SAMs were prepared using mixtures of peptide-N3 
and peptide-COOH at 0.1%, 1%, and 10% peptide-N3. The cell mixture was poured on the aptamer-conjugated 
SAMs. After 3 h of culture, non-attached cells were washed twice with PBS and the number of each type of cells 
was counted on microscopic images using ImageJ software. SAMs without conjugation of aptamers and bare gold 
surfaces were used as controls. To obtain a separation curve through multistep enrichment of target cells, separation 
with the oligopeptide SAM was examined using cell suspensions at various ratios of Hep G2 cells to RFP-HNDFCs 
or normal human hepatocytes. In both cases, the cell density was 2.0 × 105 cells/2 mL/well. To distinguish Hep G2 
cells from normal human hepatocytes, Hep G2 cells were previously stained with Vybrant-Dil (Thermo Fisher, 
Japan) in DMEM without serum for 15 min at 37 °C, followed by washing thrice with DMEM supplemented with 
10% FBS. The number of fluorescently labeled and non-labeled cells was counted on microscopic images.
Potential for reductive desorption of SAM. Cyclic voltammetry was employed to determine the poten-
tial required for the reductive desorption of the aptamer-conjugated SAM from the gold surface. The modified 
gold substrate, a Ag/AgCl reference electrode, and a platinum auxiliary electrode were connected to an electro-
chemical measurement system (Metrohm Autolab, The Netherlands). Cyclic voltammograms were taken with 
the three-electrode configuration in a 0.5 M KOH solution previously deoxygenated by bubbling nitrogen gas for 
20 min. Scanning was conducted three times at 20 mV/s in the range from 0 to − 1.0 V. All potential values refer 
to those measured with respect to the Ag/AgCl electrode.
Electrochemical cell detachment. In the evaluation of detachment of cells, a hand-built culture cham-
ber (volume, 1 mL; Fig. 1B) was fabricated to facilitate cell seeding and potential application on the substrate. 
The chamber consisted of a cylindrical wall of polydimethylsiloxane (PDMS; ShinEtsu Chemical, Japan), the 
gold-coated glass substrate (40 mm × 50 mm, Matsunami, Japan), an iron ring, and eight neodymium magnet 
blocks (ϕ 3.0 mm, Magfin, Japan). The magnet blocks were embedded in the PDMS so that the gold substrate 
was pinched between the PDMS and the iron ring by magnetic forces. The gold substrate was modified with the 
oligopeptides (peptide-COOH: peptide-N3, 9:1) and the aptamer as described above. Hep G2 cells were seeded 
in the culture chamber at a density of 1.0 × 105 cells/2 ml/well and cultured for 3 h. After the culture surface was 
rinsed twice with PBS, the gold substrate and an Ag/AgCl reference electrode were connected to a potentiostat 
(HA-151, Hokuto Denko, Japan). After applying −1.0 V for 5 min and gently rinsing with PBS, phase-contrast 
microscopic images were acquired to quantify the remaining cells. Control experiments were conducted in the 
same manner but without potential application. Detached cells were collected to examine cell viability using live/
dead fluorescent staining with fluorescein diacetate and ethidium bromide. In the evaluation of proliferation 
activity, detached cells were re-seeded in a conventional 24-well plate at 1 × 104 cells/500 μ L/well and cultured for 
5 days. Phase-contrast images were obtained every 24 h to quantify the growth rate of cells. The growth rate was 
compared with that of cells detached using 0.25% trypsin-EDTA.
Evaluation of liver-specific functions. To examine the influence of cell detachment and enrichment on 
cell functions, the secretion of two liver-specific proteins, albumin and fibrinogen, was measured after capture 
and electrochemical detachment using the aptamer-conjugated SAM. In the evaluations, a mixed cell suspension 
of Hep G2 cells and HNDFCs (1.0 × 105 cells/mL for each cell line) was seeded on the aptamer-conjugated SAM 
(3% aptamer density) and cultured for 3 h. Cells that remained attached on the SAM surface were detached 
electrochemically as described above and re-seeded in a 24-well culture plate at 3.0 × 104 cells/500 μ L/well. Cells 
that did not attach on the SAM surface were collected and re-seeded in a 24-well plate at the same cell density 
for comparison. The original suspension of Hep G2 cells and HNDFCs (1.0 × 105 cells/mL for each cell line) was 
seeded in a 24-well culture plate at the same cell density as another control. Culture media in these three systems 
were sampled every 24 h. The amounts of albumin and fibrinogen in the samples were analyzed using sandwich 
ELISA assay kits according to the manufacturer’s instructions (Abcam, Japan).
Data analysis. The number of experiments is described in the figure captions. Numerical variables were 
statistically evaluated by Student’s t-test for Figs 3 and 5. A value of p < 0.05 was considered significant.
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